Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Oxyclozanide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/12/2020
CAP-1002
Potential treatment - clinical evidence Used to treat other disease Other treatment May/12/2020
Cilengitide
Potential treatment - theoretical effect Used to treat other disease Antiviral May/11/2020
Heparan sulphate
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/10/2020
Sodium pyruvate
Potential treatment - theoretical effect Used to treat other disease Other treatment May/09/2020
Pudilan Xiaoyan
Potential treatment - pre-clinical evidence Natural product Antiviral May/08/2020
VHH-72-VHH-72
Potential treatment - pre-clinical evidence Experimental Antiviral May/05/2020
VHH-72-Fc
Potential treatment - pre-clinical evidence Experimental Antiviral May/05/2020
Tanespimycin
Potential treatment - pre-clinical evidence Experimental Antiviral May/05/2020
Mycophenolic acid
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/05/2020
Delavirdine
Potential treatment - theoretical effect Used to treat other disease Antiviral May/04/2020
Cefuroxime axetil
Potential treatment - theoretical effect Used to treat other disease Antiviral May/04/2020
Prevacid
Potential treatment - theoretical effect Used to treat other disease Antiviral May/04/2020
Da Yuan Yin
Potential treatment - clinical evidence Natural product Antiviral May/04/2020
Shuang Huang Lian Kou Fu Ye
Potential treatment - clinical evidence Natural product Antiviral May/04/2020
Bu Huan Jin Zheng Qi San
Potential treatment - clinical evidence Natural product Antiviral May/04/2020
4A3
Potential treatment - pre-clinical evidence Experimental Antiviral May/03/2020
4A12
Potential treatment - pre-clinical evidence Experimental Antiviral May/03/2020
4D5
Potential treatment - pre-clinical evidence Experimental Antiviral May/03/2020
4A10
Potential treatment - pre-clinical evidence Experimental Antiviral May/03/2020